Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
8121 - 8130 of 8404 Results
Title
Year
  • Year
  • 2010
  • 2010
  • 2010
  • 2010
  • 2010
  • 2010
  • 2010
  • 2010
  • 2010
  • 2010
  • Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment
    2010
    Summary Details
    OPEN
    Title: Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment
    Author(s): Charles H. Adler, John N. Caviness, Marwan N. Sabbagh, Holly A. Shill, Donald J. Connor, Lucia I. Sue, Virgilio Gerald H. Evidente, Erika Driver‐Dunckley, Thomas G. Beach
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Vol: 120
    Issue #: 6
    Start Page: 827
    End Page: 828
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-010-0744-4
    Best OA location URL: https://europepmc.org/articles/pmc3100801?pdf=render
    Citation Count: 83
  • Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease
    2010
    Summary Details
    OPEN
    Title: Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease
    Author(s): Danqing Xiao, J. Cassin, Brian C. Healy, Thomas C. Burdett, Jiang‐Fan Chen, Bertil B. Fredholm, Michael A. Schwarzschild
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Vol: 1367
    Issue #:
    Start Page: 310
    End Page: 318
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2010.08.099
    Best OA location URL: https://europepmc.org/articles/pmc3005012?pdf=render
    Citation Count: 48
  • CSF Aβ42 and tau in Parkinson's disease with cognitive impairment
    2010
    Summary Details
    OPEN
    Title: CSF Aβ42 and tau in Parkinson's disease with cognitive impairment
    Author(s): Thomas J. Montine, Min Shi, Joseph F. Quinn, Elaine R. Peskind, Suzanne Craft, Carmen Ginghină, Kathryn A. Chung, Hojoong Kim, Douglas Galasko, Joseph Jankovic, Cyrus P. Zabetian, James B. Leverenz, Jing Zhang
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 25
    Issue #: 15
    Start Page: 2682
    End Page: 2685
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23287
    Best OA location URL: https://europepmc.org/articles/pmc2978754?pdf=render
    Citation Count: 173
  • LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease
    2010
    Summary Details
    OPEN
    Title: LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease
    Author(s): Rachel Saunders‐Pullman, Matthew J. Barrett, Kaili Stanley, Marta San Luciano, Vicki Shanker, Lawrence Severt, Ann Hunt, Deborah Raymond, Laurie J. Ozelius, Susan Bressman
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 25
    Issue #: 15
    Start Page: 2536
    End Page: 2541
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23314
    Best OA location URL: https://europepmc.org/articles/pmc2978749?pdf=render
    Citation Count: 64
  • Systemic Weakness After Therapeutic Injections of Botulinum Toxin A
    2010
    Summary Details
    RESTRICTED
    Title: Systemic Weakness After Therapeutic Injections of Botulinum Toxin A
    Author(s): Beth E. Crowner, Diego Torres‐Russotto, Alexandre R. Carter, Brad A. Racette
    Journal Name: Clinical Neuropharmacology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 33
    Issue #: 5
    Start Page: 243
    End Page: 247
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/wnf.0b013e3181f5329e
    Best OA location URL: https://europepmc.org/articles/pmc3563356?pdf=render
    Citation Count: 79
  • Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
    2010
    Summary Details
    OPEN
    Title: Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
    Author(s): Byoung Dae Lee, Joo‐Ho Shin, Jackalina VanKampen, Leonard Petrucelli, Andrew B. West, Han Seok Ko, Yun-Il Lee, Kathleen A. Maguire‐Zeiss, William J. Bowers, Howard J. Federoff, Valina L. Dawson, Ted M. Dawson
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Vol: 16
    Issue #: 9
    Start Page: 998
    End Page: 1000
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nm.2199
    Best OA location URL: https://europepmc.org/articles/pmc2935926?pdf=render
    Citation Count: 368
  • Clinical expression of LRRK2 G2019S mutations in the elderly
    2010
    Summary Details
    OPEN
    Title: Clinical expression of LRRK2 G2019S mutations in the elderly
    Author(s): Marta San Luciano, Richard B. Lipton, Cuiling Wang, Mindy J. Katz, Molly E. Zimmerman, Amy E. Sanders, Laurie J. Ozelius, Susan Bressman, Rachel Saunders‐Pullman
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 25
    Issue #: 15
    Start Page: 2571
    End Page: 2576
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23330
    Best OA location URL: https://europepmc.org/articles/pmc2978804?pdf=render
    Citation Count: 23
  • Heart rate changes during freezing of gait in patients with Parkinson's disease
    2010
    Summary Details
    OPEN
    Title: Heart rate changes during freezing of gait in patients with Parkinson's disease
    Author(s): Inbal Maidan, Meir Plotnik, Anat Mirelman, Aner Weiss, Nir Giladi, Jeffrey M. Hausdorff
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 25
    Issue #: 14
    Start Page: 2346
    End Page: 2354
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23280
    Best OA location URL: https://europepmc.org/articles/pmc2964413?pdf=render
    Citation Count: 58
  • Glutamate Receptor Ion Channels: Structure, Regulation, and Function
    2010
    Summary Details
    RESTRICTED
    Title: Glutamate Receptor Ion Channels: Structure, Regulation, and Function
    Author(s): Stephen F. Traynelis, Lonnie P. Wollmuth, Chris J. McBain, Frank S. Menniti, Katie M. Vance, Kevin K. Ogden, Kasper B. Hansen, Hongjie Yuan, Scott J. Myers, Raymond Dingledine
    Journal Name: Pharmacological Reviews
    Publisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)
    Vol: 62
    Issue #: 3
    Start Page: 405
    End Page: 496
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1124/pr.109.002451
    Best OA location URL: https://europepmc.org/articles/pmc2964903?pdf=render
    Citation Count: 2923
  • Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
    2010
    Summary Details
    OPEN
    Title: Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
    Author(s): Taye H. Hamza, Cyrus P. Zabetian, Albert Tenesa, Alain Laederach, Jennifer S. Montimurro, Dora Yearout, Denise M. Kay, Kimberly F. Doheny, Justin Paschall, Elizabeth Pugh, Victoria I. Kusel, Randall V. Collura, John W. Roberts, Alida Griffith, Ali Samii, William K. Scott, John G. Nutt, Stewart A. Factor, Haydeh Payami
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Vol: 42
    Issue #: 9
    Start Page: 781
    End Page: 785
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ng.642
    Best OA location URL: https://europepmc.org/articles/pmc2930111?pdf=render
    Citation Count: 754
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.